Thank you, Mr. Chair.
Thank you to the witnesses for being here. I'm sorry that we had to deal with some of the protocols of the House, unfortunately, with interruptions, etc., but I appreciate your being here. You all made some significant points in your opening presentations that I think we all wanted to hear.
Dr. Goyer, you talked about something that I agree with 100%—diagnosis first, which then leads to treatment. I appreciate that comment, because I think it needs to resonate a lot more with people.
Ultimately, I think what we're looking at here is that we need to be recovery-oriented. I think that's being missed. Recovery orientation needs to be one of the biggest focuses we have. I come from Saskatchewan. I come from a very rural area. I have with me basically the OAT standards from the College of Pharmacy Professionals, as well as basically a map of what's going on in Saskatchewan right now in terms of where doctors are even trained to do it. That's a huge aspect: How do we make certain that we have that access to these rural areas? To me, I see that the focus is apparently on the big cities and not rural Canada. That's important.
Dr. Kahan, you talked a little bit about rural areas. I'm wondering if you could comment. Basically, when we look at best practices and things that we need to look at, is it valuable to be putting in a safe supply, or more so for an OAT program?